16 – 18 November 2021
People with T2D are automatically at high risk of cardiovascular diseases due to the strong association between these conditions. The aim of that presentation is to have a closer look at the CVD risk assessment for patients with type 2 diabetes.
One of the challenges in oncology is the identification of patients at high risk and catch the disease as fast as possible. Biomarkers can be an aid in surveillance and diagnosis for a disease often diagnosed too late and HCC is one of the examples.
Associate Professor, Head of Department of Infectious Diseases and Hepatology of Medical University of Silesia, Katowice, Poland
Author and co-author of over 150 original publications in journals indexed in Current Contents (H-index 25), focusing on clinical and molecular aspects of viral hepatitis, several book chapters, and review articles as well as numerous international conference presentations. His original article on the significance of HBsAg quantification during the natural course of persistent HBV infection has been cited over 500 times. Vice President of Polish Association of the Study of Liver (PASL), member of EASL ‘s Task Force on Liver Cancer Prevention, founder member of Central European Hepatologic Collaboration (CEHC), and a member of the polish group of experts in HBV, NAFLD, and COVID-19.
Chief of Laboratory Department, PhD - Reproductive Genetics Clinic “Victoria”
Author of 30 publications on cytogenetics, embryology, and prenatal screening. She was twice awarded the prize "For the best scientific work" among young scientists of NMU. O. Bogomolets. She was awarded a diploma "For significant contribution to the development and implementation of ART in Ukraine, many years of work and high professionalism." Specializes in genetics. Provides services for genetic screening, in vitro fertilization, and consultancy
Associate Professor, MD, at Kiev Medical University of UAFM
21 years of medical experience
Direction: diagnosis and correction of vitamin D deficiency, metabolic bone diseases, diagnosis and treatment of systemic osteoporosis (primary and secondary) in children, hypermobility syndrome, syndrome of undifferentiated connective tissue dysplasia
Vice Chancellor for Science and Technology Transfer, Medical University of Warsaw
Vice-Rector for Science and Technology Transfer at the Medical University of Warsaw, Head of the Department of Internal Diseases and Cardiology of the Center for Diagnostics of Treatment of Venous Thromboembolism, University Clinical Center of the Medical University of Warsaw.